share_log

Illumina | SC 13G: Statement of acquisition of beneficial ownership by individuals-Illumina, Inc.(14.5%)

Illumina | SC 13G: Statement of acquisition of beneficial ownership by individuals-Illumina, Inc.(14.5%)

Illumina | SC 13G：超過5%持股股東披露文件-Illumina, Inc.(14.5%)
美股SEC公告 ·  08/15 04:53

牛牛AI助理已提取核心訊息

Illumina, Inc., a biotechnology company based in Delaware, has filed a Schedule 13G with the U.S. Securities and Exchange Commission on August 14, 2024, indicating a significant ownership stake in GRAIL, Inc. following a corporate spin-off. On June 24, 2024, Illumina completed the distribution of approximately 85.5% of GRAIL's common stock to Illumina's shareholders. Post spin-off, Illumina retained direct ownership of 4,502,126 shares, representing 14.5% of GRAIL's outstanding common stock. The filing also notes that Illumina has granted GRAIL a proxy to vote its shares in alignment with the majority of GRAIL's stockholders. The reported ownership percentage is based on 31,049,148 shares of GRAIL's common stock outstanding as of August 11, 2024.
Illumina, Inc., a biotechnology company based in Delaware, has filed a Schedule 13G with the U.S. Securities and Exchange Commission on August 14, 2024, indicating a significant ownership stake in GRAIL, Inc. following a corporate spin-off. On June 24, 2024, Illumina completed the distribution of approximately 85.5% of GRAIL's common stock to Illumina's shareholders. Post spin-off, Illumina retained direct ownership of 4,502,126 shares, representing 14.5% of GRAIL's outstanding common stock. The filing also notes that Illumina has granted GRAIL a proxy to vote its shares in alignment with the majority of GRAIL's stockholders. The reported ownership percentage is based on 31,049,148 shares of GRAIL's common stock outstanding as of August 11, 2024.
生物技術公司 illumina，總部位於德拉華州，在2024年8月14日向美國證券交易委員會提交13G表格，表示其在GRAIL公司分離後持有該公司的重要股權。2024年6月24日，Illumina向其股東分發了GRAIL普通股約85.5%的股份。分離後，illumina直接持有4502126股，佔GRAIL已發行普通股的14.5%。文件還指出，Illumina已向GRAIL授予代理權，以與GRAIL的大多數股東投票保持一致。報告的所有權比例基於2024年8月11日GRAIL普通股已發行股份達到31049148股。
生物技術公司 illumina，總部位於德拉華州，在2024年8月14日向美國證券交易委員會提交13G表格，表示其在GRAIL公司分離後持有該公司的重要股權。2024年6月24日，Illumina向其股東分發了GRAIL普通股約85.5%的股份。分離後，illumina直接持有4502126股，佔GRAIL已發行普通股的14.5%。文件還指出，Illumina已向GRAIL授予代理權，以與GRAIL的大多數股東投票保持一致。報告的所有權比例基於2024年8月11日GRAIL普通股已發行股份達到31049148股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間